跳至主要内容
临床试验/ACTRN12621000044820
ACTRN12621000044820已完成未知

A Phase II Trial to Assess Feasibility of Using Nasal Cannula High Flow Therapy for Breathlessness in Participants with Chronic Obstructive Pulmonary Disease who do not qualify for domiciliary long-term oxygen therapy.

Melbourne Health0 个研究点目标入组 15 人开始时间: 2021年1月18日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Underlying diagnosis of severe COPD – evidence on pulmonary function tests performed within the last 24 months of Forced Expiratory Ratio (FER) <70% and Forced Expiratory Volume 1sec (FEV1) <50%
  • Physician confirmed optimisation of treatment of underlying disease
  • Breathlessness scale: Level 3 or above on the modified Medical Research Council (mMRC) dyspnoea scale (Bausewein, et al., 2007)
  • Not currently using domiciliary long-term oxygen therapy at rest via a concentrator for 16 hours/day (oxygen saturations > 92% at rest). However patients who only use exertional oxygen therapy from portable oxygen cylinders for exertion induced hypoxaemia are eligible
  • Able and willing to provide written informed consent
  • Capable of completing assessments and complying with the study procedures

排除标准

  • Acute exacerbations of COPD in the past four weeks (i.e. unstable disease)
  • Enrolment in other clinical trials that may impact study outcomes (e.g. trials on breathlessness, opioids, benzodiazepines)
  • Commenced on opioids or benzodiazepines within the last 14 days or requiring commencement of these medications while on study. Patients who were commenced on slow or immediate release opioids or benzodiazepines >14 days prior to study enrolment may continue to use these while on study.
  • Previous adverse reaction to NHF
  • Clinician predicted survival less than seven days
  • Pregnant or breastfeeding
  • Chronic alcoholism or drug abuse
  • Contraindications to NHF use:
  • oRequiring Non-Invasive or Invasive ventilation
  • oAltered level of consciousness (GCS 10 or below)
  • oSuspected or known base of skull fracture
  • oInability to maintain own airway or unable to tolerate nasal prongs
  • oRecent surgery (in last 30 days) to the nose or upper airway - including pituitary surgery via a trans sphenoidal approach
  • oSignificant facial fractures or trauma in last 30 days
  • oNasal obstruction or nasal packing

研究者

相似试验

招募中
2 期
Phase II study on the feasibility and efficacy of consolidation with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory aggressive B-cell non-Hodgkin*s lymphoma having achieved partial or complete remission after induction with R-PECC chemotherapy.Aggressive B-cell NHL10025320lymphoma
NL-OMON36830HOVO60
进行中(未招募)
不适用
Phase II study on the feasibility and efficacy of R-DHAP + HD-MTX, combined with intrathecal rituximab, followed by autologous stem cell transplantation in patients with a recurrent aggressive B-cell lymphoma with CNS localisation - HOVON 80 NHrelapsed B cell lymphomaMedDRA version: 8.1Level: LLTClassification code 10029547Term: Non-Hodgkin's lymphoma
EUCTR2006-002141-37-NLHOVON foundation35
进行中(未招募)
不适用
Phase II study on the feasibility and efficacy of consolidation with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma having achieved partial or complete remission after induction with R-PECC chemotherapy.Aggressive B-cell NHLMedDRA version: 14.1Level: PTClassification code 10003902Term: B-cell lymphoma recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10003903Term: B-cell lymphoma refractorySystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2006-007083-28-NLHOVON foundation60
尚未招募
2 期
Effect of nasyakarma/nasal drops with dhanwanthara taila 101 oil in greeva hundana/cervical spondylosis
CTRI/2017/09/009692Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
已完成
2 期
A phase II study on the feasibility and efficacy of preoperative chemoradiotherapy with S-1 for locally advanced rectal cancerrectal cancer
JPRN-UMIN000023621Department of Surgery Kindai University Faculty of Medicine42